Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 2,397,000 | 2,366,000 | 2,288,000 | 2,295,000 | 2,338,000 |
| Cost of Goods | 1,593,000 | 1,595,000 | 1,552,000 | 1,541,000 | 1,546,000 |
| Gross Profit | 804,000 | 771,000 | 736,000 | 754,000 | 792,000 |
| Operating Expenses | 449,000 | 471,000 | 469,000 | 412,000 | 444,000 |
| Operating Income | 355,000 | 300,000 | 267,000 | 342,000 | 348,000 |
| Interest Expense | 44,000 | 43,000 | 40,000 | 40,000 | 37,000 |
| Other Income | 3,000 | 17,000 | 18,000 | 3,000 | 13,000 |
| Pre-tax Income | 314,000 | 274,000 | 245,000 | 305,000 | 324,000 |
| Income Tax | 74,000 | 66,000 | 40,000 | 68,000 | 75,000 |
| Net Income Continuous | 240,000 | 208,000 | 205,000 | 237,000 | 249,000 |
| Minority Interests | 11,000 | 14,000 | 13,000 | 12,000 | 14,000 |
| Net Income | $229,000 | $194,000 | $192,000 | $225,000 | $235,000 |
| EPS Basic Total Ops | 2.05 | 1.74 | 1.72 | 1.99 | 2.08 |
| EPS Basic Continuous Ops | 2.16 | 1.87 | 1.83 | 2.12 | 2.22 |
| EPS Diluted Total Ops | 2.03 | 1.72 | 1.70 | 1.96 | 2.05 |
| EPS Diluted Continuous Ops | 2.14 | 1.86 | 1.85 | 2.08 | 2.18 |
| EPS Diluted Before Non-Recurring Items | 2.35 | 2.04 | 2.15 | N/A | N/A |
| EBITDA(a) | $472,000 | $416,000 | $376,000 | $453,000 | $460,000 |